State Street Corp decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 53.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,991,079 shares of the company's stock after selling 7,946,991 shares during the quarter. State Street Corp owned approximately 3.35% of HCA Healthcare worth $2,983,373,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. MidFirst Bank bought a new position in shares of HCA Healthcare in the second quarter valued at about $28,000. Clearstead Trust LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter worth about $29,000. Latitude Advisors LLC acquired a new position in HCA Healthcare in the 3rd quarter valued at about $32,000. Delos Wealth Advisors LLC bought a new position in HCA Healthcare in the 2nd quarter valued at about $35,000. Finally, Laurel Wealth Advisors LLC bought a new position in HCA Healthcare in the 3rd quarter valued at about $40,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, SVP Erica Rossitto sold 3,500 shares of the company's stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the completion of the sale, the senior vice president owned 13,426 shares of the company's stock, valued at approximately $6,791,005.06. This represents a 20.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Jon M. Foster sold 21,713 shares of HCA Healthcare stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the transaction, the chief operating officer directly owned 10,000 shares in the company, valued at $4,949,500. This trade represents a 68.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 36,413 shares of company stock worth $18,251,464 over the last ninety days. Corporate insiders own 1.50% of the company's stock.
Latest HCA Healthcare News
Investors following HCA have been watching these news items:
HCA Healthcare Price Performance
HCA Healthcare stock opened at $475.27 on Friday. The firm has a market cap of $99.28 billion, a PE ratio of 15.75, a price-to-earnings-growth ratio of 1.59 and a beta of 1.11. The stock's fifty day moving average price is $459.70 and its two-hundred day moving average price is $445.75. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating analysts' consensus estimates of $6.65 by $0.57. The firm had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company's revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company posted $6.96 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.14 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 10.34%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on HCA shares. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, October 31st. Morgan Stanley lowered their target price on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating on the stock in a research note on Monday, July 27th. Robert W. Baird lifted their price target on HCA Healthcare from $393.00 to $409.00 and gave the stock a "neutral" rating in a report on Wednesday, October 28th. UBS Group decreased their price objective on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Finally, Deutsche Bank set a $476.00 price objective on HCA Healthcare in a research report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $482.30.
Check Out Our Latest Stock Analysis on HCA Healthcare
HCA Healthcare Profile
(
Free Report)
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Articles
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.